Back to results
TerminatedPhase 2

Endovascular NeuromoDulation Treatment fOr Heart Failure Patients (ENDO-HF)

NCT02633644

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

OLV Hospital

Aalst, Belgium

+4 additional locations

View on ClinicalTrials.gov
Endovascular NeuromoDulation Treatment fOr Heart Failure Patients (ENDO-HF) — TrialFind